Chromosomal disorders associated with epilepsy

Epileptic Disorders

Volumn 7, Issue 3, 2005, Pages 181-192

  Battaglia, Agatino ^a   Guerrini, Renzo ^a,b  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Chromosomal disorders; Epilepsy; Malformation syndromes; Seizures

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM VALPROIC ACID; CORTICOTROPIN; STEROID; UNCLASSIFIED DRUG; VALPROIC ACID DERIVATIVE; VIGABATRIN;

CHROMOSOMAL INSTABILITY; CHROMOSOME 14; CHROMOSOME 20; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; CLINICAL FEATURE; CYTOGENETICS; DEL 1P36 SYNDROME; DOWN SYNDROME; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FRAGILE X SYNDROME; HAPPY PUPPET SYNDROME; HUMAN; KLINEFELTER SYNDROME; MALE; MENTAL DEFICIENCY; MORBIDITY; MYOCLONIC ASTATIC EPILEPSY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RING CHROMOSOME; TRISOMY 12; WOLF HIRSCHHORN SYNDROME;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; EPILEPSY; HUMANS;

EID: 25844523375     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. Aguglia U, Le Piane E, Gambardella A, et al. Emotion-induced myoclonic absence-like seizures in a patient with inv-dup(15) syndrome: a clinical, EEG, and molecular genetic study. Epilepsia 1999; 40: 1316-9.
2. Allen TL, Brothman AR, Carey JC, Chance PF. Cytogenetic and molecular analysis in trysomy 12p. Am J Med Genet 1996; 63: 250-6.
3. Angelman H. "Puppet" children: a report on three cases. Dev Med Child Neurol 1965; 7: 681-3.
4. Battaglia A, Carey JC, Cederholm P, Viskochil DH, Brothman AR, Galasso C. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999a; 103: 830-6.
5. Battaglia A, Carey JC, Cederholm P, Viskochil DH, Brothman AR, Galasso C. Storia naturale della sindrome di Wolf-Hirschhorn: esperienza con 15 casi. Pediatrics 1999b; 11: 236-42; (edizione italiana-Milano).
6. Battaglia A, Carey JC, Wright TJ. Wolf-Hirschhorn (4p-) syndrome. Adv Pediatr 2001; 48: 75-113.
7. Battaglia A, Carey JC, Wright TJ. Wolf-Hirschhorn syndrome. In: GeneReviews: Genetic Disease Online Reviews at GeneTests - GeneClinics (database online). Copyright. Seattle: University of Washington, 2002-2004; (Available at: http.//www.geneclinics.org).
8. Battaglia A, Carey JC. Health supervision and anticipatory guidance of individuals with Wolf-Hirschhorn syndrome. Am J Med Genet 1999; 89: 111-5; (Semin Med Genet).
9. Battaglia A, Carey JC. Natural history of seizures and EEC patterns in Wolf-Hirschhorn (4p-) syndrome. In preparation.
10. Battaglia A, Carey JC. Seizure and EEC patterns in Wolf-Hirschhorn (4p-) syndrome. Brain Dev 2005; 27: 362-4.
11. Battaglia A, Carey JC. Update on the clinical features and natural history of Wolf-Hirschhorn syndrome (WHS): experience with 48 cases. Am J Hum Genet 2000; 6: 127.
12. Battaglia A, Gurrieri F, Bertini E, et al. The inv dup(15) syndrome: a clinically recognizable syndrome with altered behaviour, mental retardation and epilepsy. Neurology 1997; 48: 1081-6.
13. Battaglia A, Gurrieri F. Case of apparent Gurrieri syndrome showing molecular findings of Angelman syndrome. Am J Med Genet 1999; 82: 100.
14. Battaglia A, Viskochil DH, Lewin SO, et al. 1p deletion syndrome: further clinical characterisation of a common, important and often missed cause of developmental delay/mental retardation. Proceed Greenwood Genet Ctr 2004; 23: 140-1.
15. Battaglia A. Del 1p36 syndrome: a newly emerging clinical entity. Brain Dev 2005a; 27: 358-61.
16. Battaglia A. Sindrome di Wolf-Hirschhorn (4p-): una causa di ritardo mentale grave di difficile diagnosi. Riv Ital Pediatr 1997; 23: 254-9; (I]P).
17. Battaglia A. Wolf-Hirschhorn (4p-) syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. Hoboken: John Wiley & Sons Inc, 2005b: 667-76.
18. Battaglia A. The inv dup(15) or idic(15) syndrome: a clinically recognisable neurogenetic disorder. Brain Dev 2005c; 27: 365-9.
19. Becker KL, Hoffman DL, Albert A, Underdahl LO, Mason HL. Klinefelter's syndrome: clinical and laboratory findings in 50 patients. Arch Intern Med 1966; 118: 314-21.
20. Biegel JA, White PS, Marshall HN. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 1993; 52: 176-82.
21. Biraben A, Odent S, Lucas J, et al. Chromosome 20 en anneau et épilepsie: diversité des crises étudiées en vidéo-EEC. Un mécanisme sous-cortical d'épileptogé nèse est-il au premier plan? Epilepsies 2001; 13: 9-15.
22. Blennow E, Bui TH, Wallin A, Kogner P. Monosomy 1p36.31-33→pter due to a paternal reciprocal translocation: prognostic significance of FISH analysis. Am J Med Genet 1996; 65: 60-7.
23. Blennow E, Nielsen KB, Telenius H, et al. Fifty probands with extra structurally abnormal chromosomes characterized by fluorescence in situ hybridization. Am J Med Genet 1995; 55: 85-94.
24. Bolthauser E, Meyer M, Deonna T. Klinefelter's syndrome and neurological disease. J Neurol 1978; 219: 253-9.
25. Borgatti R, Piccinelli P, Passoni D, et al. Relationship between clinical and genetic features in 'inverted duplicated chromosome 15' patients. Pediatr Neurol 2001; 24: 111-6.
26. Bower BD, Jeavons PM. The "happy puppet" syndrome. Arch Dis Childh 1967; 42: 298-302.
27. Boyd SG, Harden A, Patton MA. The EEC in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 1988; 147: 508-13.
28. Brandt CA, Kierkegaard O, Hindkjaer J, Jensen PKA, Pedersen S, Therkelsen AJ. Ring chromosome 20 with loss of telomeric sequences detected by multicolour PRINS. Clin Genet 1993; 44: 26-31.
29. Brown WT. The molecular biology of the fragile X mutation. In: Hagerman RJ, Hagerman PJ, eds. 3rd ed. Fragile X syndrome: Diagnosis, treatment and research. Baltimore: Johns Hopkins University Press, 2002: 110-35.
30. Buckle VJ, Fujita N, Ryder-Cook AS, et al. Chromosomal localization of GABA(A) receptor beta-a-3-subunit gene. Neuron 1989; 3: 647-54.
31. Cabrera JC, Marti M, Toledo L, Gine R, Vazquez C. West's syndrome associated with inversion duplication of chromosome 15. Rev Neurol (Spain) 1998; 26: 77-9.
32. Canevini MP, et al. Chromosome 20 ring: a chromosomal disorder associated with a particular electroclinical pattern. Epilepsia 1998; 39: 942-51.
33. Centerwall WR, Thompson WP, Allen IE, Fobes CD. Translocation 4p- syndrome. Am J Dis Child 1975; 129: 366-70.
34. Cheng SD, Spinner NB, Zackai EH, Knoll JH. Cytogenetic and molecular characterization of inverted duplicated chromosomes 15 from 11 patients. Am J Hum Genet 1994; 55: 753-9.
35. Chifari R, Guerrini R, Pierluigi M, et al. Mild generalized epilepsy and developmental disorder associated with large inv dup(15). Epilepsia 2002; 43: 1096-100.
36. Cooper H, Hirschhorn K. Apparent deletion of short arms of one chromosome (4 or 5) in a child with defects of midline fusion. Mammalian Chrom Nwsl 1961; 4: 14.
37. Dalla Bernardina B, Zullini E, Fontana E, Colamaria V, Cappellaro O, Avesani E. Sindrome di Angelman: studio EEG-poligrafico di 8 casi. Boll Lega It Epil 1992: 257-9; (79/80).
38. Dallapiccola B, Mandich P, Bellone E, et al. Parental origin of chromosome 4p deletion in Wolf-Hirschhorn syndrome. Am J Med Genet 1993; 47: 921-4.
39. De Grouchy J, Turleau C. Clinical atlas of human chromosomes. 2nd ed. New York: John Wiley, 1984.
40. Dombrowski C, Levesque ML, Morel ML, Roulliard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 2002; 11: 371-8.
41. Donlon TA, Lalande M, Wyman A, Bruns G, Latt SA. Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi syndrome. Proc Natl Acad Sci USA 1986; 83: 4408-12.
42. Elia M, Guerrini R, Musumeci SA, Bonanni P, Gambardella A, Aguglia U. Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia 1998; 39: 660-3.
43. Elia M, Musumeci SA, Ferri R, Scuderi C, Del Gracco S, Stefanini MC. Seizures in Klinefelter's syndrome: a clinical and EEG study of five patients. Ital J Neurol Sci 1995; 16: 231-8.
44. Endele S, Fuhry M, Pak SJ, Zabel BU, Winterpacht A. LETM1, a novel gene encoding a putative EF-Hand Ca-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients. Genomics 1999; 60: 218-25.
45. Epstein CJ. Down syndrome. In: Rosenberg RN, Prusiner SB, Di Mauro S, Barchi RL, eds. The molecular and genetic basis of neurological diseases. Boston: Butterworth-Heinemann, 1997: 51-79.
46. Estabrooks LL, Lamb AN, Aylsworth AS, Callanan NP, Rao KW. Molecular characterization of chromosome 4p deletions resulting in Wolf-Hirschhorn syndrome. J Med Genet 1994; 31: 103-7.
47. Eugster EA, Berry SA, Hirsch B. Mosaicism for deletion 1p36.33 in a patient with obesity and hyperphagia. Am J Med Genet 1997; 70: 409-12.
48. Faivre L, Morichon-Delvallez N, Vior G, et al. Prenatal detection of a 1p36 deletion in a fetus with multiple malformations and a review of the literature. Pren Diagn 1999; 19: 49-53.
49. Friede RL. Developmental neuropathology. 2th ed. Berlin Heidelberg: Springer-Verlag, 1989.
50. Fryns JP, Kubien E, Kleczkowska A, et al. Ring chromosome 14: a distinct clinical entity. J Hum Genet 1983; 31: 367-75.
51. Genton P, Medina MT, Roger J, Murcia de Medina M, Mattei MG, Guerrini R. Syndrome de Klinefelter (dysgénésie gonadique avec caryotype 47, XXY) et épilepsie: 5 observations. Boll Lega It Epil 1992: 69-70; (79/80).
52. Gillberg C, Steffenburg S, Wahlstrom J, et al. Autism associated with marker chromosome. J Am Acad Child Adolesc Psychiat 1991; 30: 489-94.
53. Gimenez-Roldan S, Martin M. Startle epilepsy complicating Down syndrome during adulthood. Ann Neurol 1980; 7: 78-80.
54. Giraudeau F, Aubert D, Young I, et al. Molecular cytogenetic detection of a deletion of 1p36.3. J Med Genet 1997; 34: 314-7.
55. Gorlin RJ, Cohen MM, Levin LS. In: Syndromes of the head and neck. New York - Oxford: Oxford University Press, 1990: 46-8.
56. Gottfried M, Lavine L, Roessmann U. Neurpathological findings in Wolf-Hirschhorn (4p-) syndrome. Acta Neuropathol (Berl) 1981; 55: 163-5.
57. Guerrini R, Battaglia A, Mattei MG, et al. Epilessia e crisi epilettiche nella sindrome del cromosoma X fragile. Boll Lega It Epil 1992: 73-4; (79/80).
58. Guerrini R, Battaglia A, Stagi P, et al. Caratteristiche elettrocliniche dell'epilessia nella Sindrome di Down. Boll Lega It Epil 1989: 317-9; (66/67).
59. Guerrini R, Bureau M, Mattei MG, Battaglia A, Galland MC, Roger J. Trisomy 12p syndrome: a chromosomal disorder associated with generalized 3-Hz spike and wave discharges. Epilepsia 1990; 31: 557-66.
60. Guerrini R, Carrozzo R, Rinaldi R, Bonanni P. Angelman Syndrome: Etiology, Clinical Features, Diagnosis and Management of Symptoms. Pediatric Drugs 2003; 10: 647-51.
61. Guerrini R, De Lorey TM, Bonanni P, et al. Cortical myoclonus in Angelman syndrome. Ann Neurol 1996; 40: 39-48.
62. Guerrini R, Dravet C, Ferrari AR, et al. Evoluzione dell'epilessia nelle più frequenti forme genetiche con ritardo mentale, (sindrome di Down e sindrome dell'X fragile). Ped Med Chir 1993; 15:19-22; (Med Surg Ped).
63. Guerrini R, Genton P, Bureau M, Dravet C, Roger J. Reflex seizures are frequent in patients with Down syndrome and epilepsy. Epilepsia 1990; 31: 406-17.
64. Guerrini R, Gobbi G, Genton P, Bonanni P, Carrozzo R. Chromosomal abnormalities. In: Engel J, Pedley T, eds. Epilepsy-Vol.3. Philadelphia-New York: Lippincott-Raven, 1997: 2533-46.
65. Guthrie RD, Aase JM, Asper AC, Smith D. The 4p- syndrome. Am J Dis Child 1971; 122: 421-5.
66. Hagerman RJ, Staley LW, O' Conner R, et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 1996; 97: 122-6.
67. Hagerman RJ. Fragile X syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. Hoboken: John Wiley & Sons Inc, 2005: 251-63.
68. Hagerman RJ. Physical and behavioral phenotype. In: Hagerman RJ, Hagerman PJ, eds. 3rd ed. Fragile X syndrome: Diagnosis, treatment and research. Baltimore: Johns Hopkins University Press, 2002: 3-109.
69. Hain D, Leversha M, Campbell N. The ascertainment and implications of an unbalanced translocation in theneonate: Familial 1: 15 translocation. Austr Paediatr J 1980; 16: 196-200.
70. Heilstedt HA, Ballif BC, Howard LA, et al. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterisation of the syndrome. Am J Hum Genet 2003; 72: 1200-12.
71. Heilstedt HA, Burgess DL, Anderson AE, et al. Loss of the potassium channel β-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia 2001; 42: 1103-11.
72. Holmes GL. Genetics of epilepsy. In: Holmes GL, ed. Diagnosis and management of seizures in children. Philadelphia: Saunders Company, 1987: 56-71.
73. Hook EB, Cross K. Extra structurally abnormal chromosomes (ESAC) detected at amniocentesis: frequency in approximately 75,000 prenatal cytogenic diagnoses and associations with maternal and paternal age. Am J Hum Genet 1987; 54: 748-56.
74. Hook EB. Prevalence, risks and recurrence. In: Brock DJ, Ferguson-Smith MA, eds. Prenatal diagnosis and screening. London: Churchill Livingstone, 1992: 351-92.
75. Inoue Y, Fujiwara T, Matsuda K, et al. Ring chromosome 20 and nonconvulsive status epilepticus: A new epileptic syndrome. Brain 1997; 120: 939-53.
76. Jay V, Becker LE, Chan F-W, Perry TL. Puppet-like syndrome of Angelman: a pathologic and neurochemical study. Neurology 1991; 41: 416-22.
77. Jennings MT, Bird TD. Genetic influences in the epilepsies. Am J Dis Child 1981; 135: 450-7.
78. Jerrigan TL, Bellugi U, Sowell E, Doherty S, Hesselink JR. Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 1993; 50: 186-91.
79. Jorde L, Carey JC, Bamshad MJ, White LR. Medical Genetics. St. Louis: Mosby, 2003.
80. Kanazawa O, Irie N, Kawai I. Epileptic seizures in the 4p- syndrome: report of two cases. Jpn J Psychiatry Neurol 1991; 45: 653-9.
81. Keppler-Noreuil KM, Carroll AJ, Finley WH, Rutledge SL. Chromosome1p terminal deletion: report of new findings and confirmation of two characteristic phenotypes. J Med Genet 1995; 32: 619-22.
82. Knight-Jones E, Knight S, Heussler H, Regan R, Flint J, Martin K. Neurodevelopmental profile of a new dysmorphic syndrome associated with submicroscopic partial deletion of 1p36.3. Dev Med Child Neurol 2000; 42: 201-6.
83. Kuenzle C, Steinlin M, Wohlrab G, et al. Adverse effects of Vigabatrin in Angelman Syndrome. Epilepsia 1998; 39: 1213-5.
84. Kyriakides T, Hallam LA, Hockey A, Silberstein P, Kakulas BA. Angelman's syndrome: a neuropathological study. Acta Neuropathol (Berl) 1992; 83: 675-8.
85. Laan LAEM, Renier WO, Arts WFM, et al. Evolution of epilepsy and EEC findings in Angelman syndrome. Epilepsia 1997; 38: 195-9.
86. Lancman ME, Penry JK, Asconape JJ, Brotherton TA. Number 20 ring chromosome: a case with complete seizure control. J Child Neurol 1993; 8: 186-7.
87. Lazjuk GI, Lurie IW, Ostrowskaja TI, et al. The Wolf-Hirschhorn syndrome. II. Pathologic anatomy. Clin Genet 1980; 18: 6-12.
88. Lippe BM, Sparkes RS. Ring 14 chromosome: association with seizures. Am J Med Genet 1981; 9: 301-5.
89. Lorda-Sanchez I, Binkert F, Maechler M, Robinson WP, Schinzel AA. Reduced recombination and paternal age effect in Klinefelter syndrome. Hum Genet 1992; 89: 524-30.
90. Luke S, Verma RS, Giridharan R, Conte RA, Macera MJ. Two Prader-Willi/Angelman syndrome loci present in an isodicentric marker chromosome. Am J Med Genet 1994; 51: 232-3.
91. Lurie IW, Lazjuk GL, Ussova I, Presman EB, Gurevich DB. The Wolf-Hirschhorn syndrome. I. Genetics. Clin Genet 1980; 17: 375-84.
92. Magenis RE, Sheehy R, Lacey D, Brown MG, Litt M. Small terminal deletion of chromosome 1 short arm in an infant with multiple anomalies: confirmation by in situ hybridisation of probe p1-79. Am J Hum Genet 1987; 41: A130.
93. Matalon R, Supple P, Wyandt H, et al. Transmission of ring 14 chromosome from mother to two sons. Am J Med Genet 1990; 36:381-5.
94. Matsumoto A, Kumagai T, Miura K, et al. Epilepsy in Angelman syndrome associated with chromosome 15q deletion. Epilepsia 1992; 33: 1083-90.
95. Minassian B, DeLorey T, Olsen RW, et al. The epilepsy of Angelman syndrome due to deletion, disomy, imprinting center and UB3A mutations. Ann Neurol 1998; 43: 485-93.
96. Musumeci SA, Ferri R, Elia M, Cologna RM, Bergonzi P, Tassinari CA. Epilepsy and fragile X syndrome: a follow-up study. Am J Med Genet 1991; 38: 511-3.
97. Nielsen J, Pedersen E. Electro-encephalographic findings in patients with Klinefelter's syndrome and the XXY-syndrome. Acta Neurol Scand 1969; 45: 87-94.
98. Nielsen J, Venter M, Holm V, Askjaer SA, Reske-Nielsen E. A newborn child with caryotype 47, XX,+der(12)(12pter> 12q12:8q24 > 8qter), t(8; 12)(q24;q12)pat. Hum Genet 1977; 35: 357-62.
99. Ogle R, Sillence DO, Merrick A, et al. The Wolf-Hirschhorn syndrome in adulthood: evaluation of a 24-year-old man with a rec(4) chromosome. Am J Med Genet 1996; 65: 124-7.
100. Petit J, Roubertie A, Inoue Y, et al. Non-convulsive status in the ring chromosome 20 syndrome: a video illustration of 3 cases. Epileptic Disord 1999; 1: 237-41.
101. Pueschel SM, Louis S, McKnight P. Seizure disorders in Down syndrome. Arch Neurol 1991; 84: 318-20.
102. Pueschel SM, Louis S. Reflex seizures in Down syndrome. Childs Nerv Syst 1993; 9: 23-4.
103. Ray M, Chudley AE, Christie N, Seargeant L. A case of de novo trisomy 12p syndrome. Ann Genet (Paris) 1985; 28: 235-8.
104. Reid I, Morrison N, Barron L, et al. Familial Wolf-Hirschhorn syndrome resulting from a cryptic translocation: a clinical and molecular study. J Med Genet 1996; 33: 197-202.
105. Reish O, Berry SA, Hirsch B. Partial monosomy of chromosome 1p36.3: characterisation of the critical region and delineation of a syndrome. Am J Med Genet 1995; 59: 467-75.
106. Riegel M, Castellan C, Balmer D, Brecevic L, Schinzel A. Terminal deletion, del(1)(p36.3), detected through screening for terminal deletions in patients with unclassified malformation syndromes. Am J Med Genet 1999; 82: 249-53.
107. Riley SB, Buckton KE, Ratcliffe SG, et al. Inheritance of a Ring 14 chromosome. J Med Genet 1981; 18: 209-13.
108. Robinson WP, Binkert F, Gine R, et al. Clinical and molecular analysis of five inv dup (15) patients, Eur J Hum Genet 1993; 1: 37-50.
109. Roubertie A, Petit J, Genton P. Chromosome 20 en anneau: un syndrome épileptique identifiable. Rev Neurol 2000; 156: 149-53.
110. Rougelle C, Glatt H, Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet 1997; 17: 14-5; [letter].
111. Rousseau F, Roulliard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995; 57: 1006-18.
112. Sàenz-Lope E, Herranz FJ, Marsden JC. Startle epilepsy: a clinical study. Ann Neurol 1984; 16: 78-81.
113. Sandlin CJ, Dodd BS, Dumars KW, Bartley JA, Bernstein R, Lamb A. Phenotypes associated with terminal deletion of the short arm of chromosome 1. Am J Hum Genet 1995; 57: A125.
114. Schinzel A, Niedrist D. Chromosome imbalances associated with epilepsy. Am J Med Genet 2001; 106: 119-24; (Semin Med Genet).
115. Schinzel A. Catalogue of Unbalanced Chromosome Aberrations in Man. Berlin-New York: Walter de Gruyter, 2001.
116. Schmidt R, Eviatar L, Nitowski HM, et al. Ring chromosome 14: a distinct clinical entity. J Med Genet 1981; 18: 304-7.
117. Sgrò V, Riva E, Canevini MP, et al. 4p-syndrome: a chromosomal disorder associated with a particular EEC pattern. Epilepsia 1995; 36: 1206-14.
118. Shaffer LG, Heilstedt HA. Terminal deletion of 1p36. Lancet 2001; 358: 59.
119. Shapira SK, McCaskill C, Northrup H, et al. Chromosome 1p36 deletions: the clinical phenotype and molecular characterisation of a common newly delineated syndrome. Am J Hum Genet 1997; 61: 642-50.
120. Sherman S. Epidemiology. In: Hagerman RJ, Hagerman PJ, eds. 3rd ed. Fragile X syndrome: Diagnosis, treatment and research. Baltimore: Johns Hopkins University Press, 2002: 136-68.
121. Shi Q, Spriggs E, Field LL, et al. Absence of age effect on meiotic recombination between human X and Y chromosomes. Am J Hum Genet 2002; 71: 254-61.
122. Silva ML, Cieuta C, Guerrini R, Plouin P, Livet MO, Dulac O. Early clinical and EEC features of infantile spasms in Down syndrome. Epilepsia 1996; 37: 977-82.
123. Singh R, McKinley Gardner RJ, Crossland KM, Scheffer IE, Berkovic SF. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia 2002; 43: 127-40.
124. Slavotinek A, Rosenberg M, Knight S, et al. Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet 1999; 36: 405-11.
125. Slavotinek A, Shaffer LG, Shapira SK. Monosomy 1p36. J Med Genet 1999; 36: 657-63.
126. Smith GF, Berg JM. Down's anomaly. 2nd ed. Edinburgh: Churchill Livingstone, 1976.
127. Stafstrom CE, Konkol RJ. Infantile spasms in children with Down syndrome. Dev Med Chil Neurol 1994; 36: 576-85.
128. Stafstrom CE, Patxot CE, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol 1991; 33: 191-200.
129. Steffenburg S, Gillberg CL, Steffenburg U, et al. Autism in Angelman syndrome: a population-based study. Pediatr Neurol 1996; 14: 131-6.
130. Stengel-Rutkoswki S, Albert A, Murken DJ, et al. New chromosomal dysmorphic syndromes. Trisomy 12p. Eur J Pediatr 1981; 136: 249-62.
131. Stengel-Rutkowski S, Warkotsch A, Schimanek P, Stene J. Familial Wolf's syndrome with a hidden 4p deletion by translocation of an 8p segment. Unbalanced inheritance from a maternal translocation (4; 8)(p15.3; p22). Case report, review and risk estimates. Clin Genet 1984; 25: 500-21.
132. A receptor. Jpn J Psychiatry Neurol 1994; 42: 271-3.
133. Takeda Y, Baba A, Nakamura F, Ito M, Honma H, Koyama T. Symptomatic generalized epilepsy associated with an inverted duplication of chromosome 15. Seizure 2000; 9: 145-50.
134. Tassone F, Hagerman RJ, Ikle D, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 1999; 84: 250-61.
135. Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with FMR1 premutation. Am J Med Genet 2000; 91: 144-52.
136. Tatsuno M, Hayashi M, Iwamoto H, et al. Epilepsy in childhood Down syndrome. Brain Dev 1984; 6: 37-44.
137. Thomas NS, Collins AR, Hassold TJ, Jacobs PA. A reinvestigation of non-disjunction resulting in 47, XXY males of paternal origin. Eur J Hum Genet 2000; 8: 805-8.
138. Torrisi L, Sangiorgi E, Russo L, Gurrieri F. Rearrangements of chromosome 15 in epilepsy. Am J Med Genet 2001; 106: 125-8; (Semin Med Genet).
139. Tupler R, Bortotto L, Buhler EM, et al. Paternal origin of the de novo deleted chromosome 4 in Wolf-Hirschhorn syndrome. J Med Genet 1992; 29: 53-5.
140. Van Buggenhout G, Melotte C, Dutta B, et al. Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet 2004; 41: 691-8.
141. Veall RM. The prevalence of epilepsy among mongols related to age. J Ment Def Res 1974; 18: 99-106.
142. Viani F, Romeo A, Viri M, et al. Seizure and EEC patterns in Angelman's syndrome. J Child Neurol 1995; 10: 467-71.
143. Webb T, Hardy CA, King M, Watkiss E, Mitchell C, Cole T. A clinical, cytogenetic and molecular study of ten probands with inv dup (15) marker chromosomes. Clin Genet 1998; 53: 34-43.
144. Wenger SL, Steele MW, Becker DJ. Clinical consequences of deletion 1p35. J Med Genet 1988; 25: 263.
145. Williams CA. Angelman syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. Hoboken: John Wiley & Sons Inc, 2005: 53-62.
146. Wisniewski KE, Laure-Kamionowska M, Wisniewski HM. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down syndrome. N Engl J Med 1984: 1187-8.
147. Wisniewski KE, Segan SM, Miezejesji EA, Sersen EA, Rudelli RD. The Fra (X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 1991; 38: 476-80.
148. Wu YQ, Heilstedt HA, Bedell JA, et al. Molecular refinement of the 1p36 deletion syndrome reveals size diversity and a preponderance of maternally derived deletions. Hum Mol Genet 1999; 8: 313-21.
149. Yunis E, Quintero L, Lebovici M. Monosomy 1pter. Hum Genet 1981; 56: 279-82.
150. Zankl A, Addor MC, Maeder-Ingvar M, Schorderet DF. A characteristic EEC pattern in 4p- syndrome: case report and review of the literature. Eur J Pediatr 2001; 160: 123-7.
151. Zelante L, Torricelli F, Galvano S, et al. Ring chromosome 14 syndrome: report of two cases, including extended evaluation of a previously reported patient and review. Ann Genet 1991; 34: 93-7.
152. Zollino M, Lecce R, Fischetto R, et al. Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am J Hum Genet 2003; 72: 590-7.
153. Zori RT, Hendrickson J, Woolven S, et al. Angelman syndrome: clinical profile. J Child Neurol 1992; 7: 270-80.
154. Zuberi SM, Biraben AJ. Presentation, clinical evaluation and outcome in ring chromosome 20 syndrome. Brain Dev 2004; 26: 554-5 [abstract].